ONCT NASDAQ
Oncternal Therapeutics, Inc.
1W: +0.0%
1M: -24.1%
3M: -57.9%
1Y: -94.6%
3Y: -98.9%
5Y: -99.4%
$0.53
Last traded 2024-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$2M
Revenue
+265.6% YoY
$-35M
Net Income
+16.1% YoY
$-27M
Free Cash Flow
+23.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE38.5%
ROA-117.6%
ROIC542.2%
Valuation
P/E-0.0
P/B0.1
EV/EBITDA0.6
Leverage
Debt/Equity0.02
Current Ratio2.39
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-26.47
Beneish M0.00